Searchable abstracts of presentations at key conferences in endocrinology

ea0029p811 | Endocrine tumours and neoplasia | ICEECE2012

Parathyroid atypical adenomas: mutational screening of CDC73/HRPT2 gene

Pardi E. , Borsari S. , Banti C. , Saponaro F. , Torregrossa L. , Marcocci C. , Cetani F.

Atypical parathyroid adenomas represent a subset of tumors with histological features worrisome for carcinoma (PC), such as trabecular growth, fibrous bands and increased mitotic activity without unequivocal criteria of malignancy (local recurrence and/or metastasis). The question of whether these lesions might represent an anticipation of an aggressive clinical behavior that overtime may acquire the full blown features of malignancy remains to be established.<p class="abs...

ea0011p30 | Bone | ECE2006

Asymptomatic primary hyperparathyroidism: preliminary results of a prospetive randomized study on the effect of parathyroidectomy

Ambrogini E , Cianferotti L , Vignali E , Cetani F , Viccica G , Picone A , Miccoli P , Pinchera A , Marcocci C

Aim of this 2-year, prospective, randomized study is to compare the effect of parathyroidectomy (PTX) vs no treatment in patients with asymptomatic primary hyperparathyroidism (PHPT), who didn’t meet the 1991 NIH criteria for surgery. The study was approved by our local Ethical Committee. The primary endpoint was the change in lumbar spine bone mineral density (BMD); secondary endpoints were BMD changes at femur and distal radius, markers of bone turnover, quality ...

ea0011p157 | Clinical case reports | ECE2006

Small intragenic somatic mutation associated with a germline mutation of HRPT2 gene in a patient with sporadic primary hyperparathyroidism

Pardi E , Cetani F , Ambrogini E , Borsari S , Lemmi M , Pinchera A , Marcocci C

We describe a 39-yr-old man with recurrent sporadic primary hyperparathyroidism (PHPT). In 1987, at the age of 21 yr, a severe form of PHPT was diagnosed [serum calcium 17.3 mg/dl; C-PTH 3.17 ng/ml (<0.88 ng/ml), cortical thinning and erosion] and a right parathyroid adenoma was removed. Three years later recurrence of PHPT was diagnosed but no treatment was initially advised. In 1993 the patient underwent cervical exploration and a right parathyroid adenoma was excised. S...

ea0011p534 | Endocrine tumours and neoplasia | ECE2006

Novel inactivating mutations in four Italian cases of familial hypocalciuric hypercalcemia

Cetani F , Borsari S , Lemmi M , Pardi E , Ambrogini E , Pinchera A , Marcocci C

Familial Hypocalciuric Hypercalcemia (FHH) is an autosomal dominant disorder characterized by moderate and lifelong hypercalcemia, relative hypocalciuria, and inappropriately normal serum PTH levels. Loss-of-function mutation of the CaR are responsible for this disease.In this study we describe three unrelated Italian kindreds (A, B and C) and one patient with FHH. The diagnosis of FHH in the propositus was suspected on the finding of hypercalcemia, norm...

ea0029p839 | Endocrine tumours and neoplasia | ICEECE2012

Multiple endocrine neoplasia syndrome type 1 (MEN-1) in Sardinian population: low prevalence of Men-1 mutations and detection of a new inactivating mutation of the CDKI gene p27

Mastinu M. , Cetani F. , Marcocci C. , Pardi E. , Cappai A. , Satta C. , Badessi F. , Delitala A. , Lai R. , Fanciulli G. , Mariotti S.

Introduction: The genetic basis of multiple endocrine neoplasia type 1 (MEN-1) syndrome is often represented by inactivating mutations of Men-1 gene, found in 50–80% of different series. Recently, other mutations of genes encoding for the CDKI complex (p15, p18, p21, and p27) and of the AIP gene have been described in a small number of Men-1-negative patients.Methods and results: Since 2002 we tested for Men-1 mutations 16 patients born and living i...

ea0029p806 | Endocrine tumours and neoplasia | ICEECE2012

Stem cell genes are deregulated in parathyroid tumours

Vaira V. , Verdelli C. , Forno I. , Elli F. , Guarnieri V. , Ferrero S. , Scillitani A. , Costa E. , Vicentini L. , Steffano G. , Cetani F. , Spada A. , Bosari S. , Corbetta S.

In our previous investigation on microRNAs expression pattern in parathyroid carcinomas (Ca), we detected the over-expression of microRNAs belonging to C19MC, the largest human cluster on chromosome 19q13.41. In the present study, the analysis of the expression of selected C19MC and the closely distal MIR371-3 clusters microRNAs (MIR512-3p, MIR517C, MIR520H and MIR372) was extended to 11 Ca, 24 adenomas (Ad) and 6 normal glands. The four microRNAs was expressed in 11% of parat...

ea0011p535 | Endocrine tumours and neoplasia | ECE2006

Genetic analyses of familial isolated primary hyperparathyroidism: implications for clinical assessment and surgical management

Marcocci C , Pardi E , Borsari S , Ambrogini E , Lemmi M , Picone A , Vignali E , Viccica G , Berti P , Miccoli P , Cetani F

Familial isolated primary hyperparathyroidism (FIPH) can result either from incomplete expression of a syndromic form of familial primary hyperparathyroidism [multiple endocrine neoplasia types 1 (MEN 1), hyperparathyroidism-jaw tumor syndrome (HPT-JT), or familial hypocalciuric hypercalcemia (FHH)] or still unrecognized causes.We investigated the involvement of MEN1, HRPT2 and CASR genes by direct sequencing of germline DNA in seven...